Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 11, 2021 | China Immunotech | $31.0M Series B | China Growth Capital | Beijing Changping Science Park Development, Fenghai Capital, Sangel Capital, Start Point Advisors, Jianwei YUAN |